nanochannels
Bionano Genomics Seeks to Raise $34.5M in IPO
In 2017, Bionano had $9.5 million in revenues and a net loss of 23.4 million, or $7.66 per share.
With its Direct Labeling and Staining (DLS) chemistry, currently available to early-access users, Bionano is pushing forward with more contiguous genome maps.
BioNano Genomics Demonstrates Mapping of Two Human Genomes, Launches Nanochannel Platform in Europe
Premium
BioNano Genomics has launched its nanochannel-based single-molecule DNA mapping platform in Europe and plans to extend the technology to human-size genomes later this year, enabling researchers to discover new structural variants, separate haplotypes, and obtain better genome ass
BioNanomatrix has changed its name to BioNano Genomics, the company said this week.
Through the name change, the firm wants to communicate "its position as a solution provider for genomics researchers."
The Philadelphia-based Princeton University spinout plans to use $830,000 in new supplemental grant funding from the National Human Genome Research Institute to prepare for beta-testing of its NanoAnalyzer next year.